 Health Care |
Health Care |
|
|
Medicare picks Botox and Trulicity for latest round of negotiations |
The Centers for Medicare and Medicaid Services (CMS) have announced the next 15 drugs whose prices will be negotiated as part of the third round of Medicare negotiations. |
This latest round of negotiations will mark the first time that not only Medicare Part D covered drugs will be negotiated, but also drugs payable under Medicare Part B. It will also be the first time that Medicare negotiations occur while Medicare-negotiated prices are in effect, with the prices negotiated under the first round of bargaining having started on Jan. 1, 2026. Established by the Inflation Reduction Act during the Biden administration, the drugs are selected based on how much Medicare spends on them. Companies have until Feb. 28 to agree to negotiate their drug prices. "For too long, seniors and taxpayers have paid the price for skyrocketing prescription drug costs," CMS Administrator Mehmet Oz said in a statement. "Under President Trump's leadership, CMS is taking strong action to target the most expensive drugs in Medicare, negotiate fair prices, and make sure the system works for patients—not special interests. This approach delivers real savings while strengthening accountability across the program." The next 15 drugs picked for Medicare negotiation are: - Anoro Ellipta
- Biktarvy
- Botox; Botox Cosmetic
- Cimzia
- Cosentyx
- Entyvio
- Erleada
- Kisqali
- Lenvima
- Orencia
- Rexulti
- Trulicity
- Verzenio
- Xeljanz; Xeljanz XR
- Xolair
CMS added that Tradjenta had been selected for renegotiation. The agency had selected Tradjenta as part of last year's round of negotiations as well. An explanation on why it was picked for renegotiation was not given in CMS's announcement, though the agency said selection was informed by "refinements based on public feedback." |
Welcome to The Hill's Health Care newsletter, we're Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health. |
|
| How policy will be impacting the health care sector this week and beyond: |
|
|
The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including the high-cost medications Botox and Trulicity. This third cycle of negotiations is the first to include drugs payable under Medicare Part B, which are traditionally administered in clinical settings, in addition to the traditional Part D prescription drugs, according … |
| |
|
The American Academy of Pediatrics (AAP) has once again diverged from recent federal vaccine guidance, publishing its own childhood immunization schedule for 2026 that recommends vaccinating against illnesses the Centers for Disease Control and Prevention (CDC) dropped earlier this month. The AAP on Monday published its 2026 Recommended Child and Adolescent Immunization Schedule, which recommends that children be vaccinated … |
| |
|
Kirk Milhoan, a pediatric cardiologist recently appointed as chair of a highly influential federal vaccine committee, questioned the need for immunizing against illnesses like polio in a podcast interview released Thursday. He argued that public health is not the “first order” of his group. Last month, Health and Human Services Secretary Robert F. Kennedy Jr. appointed Milhoan to be chair of the Advisory Committee … |
| |
|
Branch out with a different read: |
|
|
Watch live: Vance, Johnson speak at March for Life rally |
Vice President Vance and Speaker Mike Johnson (R-La.) are scheduled to speak Friday at the annual March for Life rally in Washington, D.C. Vance and President Trump spoke to anti-abortion advocates at last year’s event. It has been held every year since 1974. Watch Friday’s remarks, scheduled to begin at 12 p.m. EST, in the player above. |
|
|
Local and state headlines on health care: |
- State health officials expand access to measles vaccine following confirmed community spread in WNC (WUNC)
- South Carolina measles outbreak surpasses Texas' 2025 total, with little sign of slowing (Stat)
- Texans are tightening their budgets to pay for health insurance after subsidies expired (Houston Public Media)
|
|
|
Health news we've flagged from other outlets: |
- Deadly Nipah virus cases reported by health officials (USA Today)
- Trump policies at odds with emerging understanding of Covid's long-term harm (KFF Health News)
- Exclusive: In major test for longevity field, FDA greenlights study on a 'near total reset' of cells (Endpoints News)
|
|
|
Opinions related to health submitted to The Hill: |
|
|
You're all caught up. See you tomorrow! |
400 N Capitol Street NW Suite 650, Washington, DC 20001 |
Copyright © 1998 - 2026 Nexstar Media Inc. | All Rights Reserved. |
|
|
|
If you believe this has been sent to you in error, please safely unsubscribe.
No comments:
Post a Comment